Innovative research on the mode of action of yeast probiotics
With our own dedicated research team, and universities around the world, we are investing in emerging research in relation to 16s rRNA sequencing. This allows us to measure simultaneously thousands of biochemical molecules derived by the host, as well as bacteria, identifying which molecular pathways are regulated by intestinal microbiota. It also shows us how these pathways are affected by antibiotic use, nutrition, and intestinal diseases.
This is helping us identify how probiotics interfere with each phylum or genera of bacteria, improving our understanding of how to modulate the microbiota, and positively influencing animal gut health in the process. Ultimately, this helps us to identify the phylum or genera of bacteria that are directly related to key performance parameters, such as average daily gain, growth rate, and feed conversion.